Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baizhang Prostatitis Capsule
- Development stage
- Phase 3
- Lead developer
- Fangsheng Pharmaceutical
- Administration
- Oral
01
Overview
Baizhang Prostatitis Capsule is a Traditional Chinese Medicine (TCM) formulation developed by Hunan Fangsheng Pharmaceutical for the treatment of chronic prostatitis. It is specifically indicated for patients presenting with the damp-heat in the lower burner pattern according to TCM diagnostics. The capsule is composed of botanical extracts, including *Polygonum cuspidatum* (Baizhang), which are traditionally used to clear heat, induce diuresis, and resolve blood stasis. In clinical trials, it is evaluated for its ability to improve symptoms such as pelvic pain and urinary dysfunction in adult men.
- Other names
- Baizhang Qianliexianyan Jiaonang
Beyond the preview
Go deeper on Baizhang Prostatitis Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baizhang Prostatitis Capsule.